TipRanks
Advertisement
Advertisement

PCACTIT Stock Latest News

Actithera Highlights Growth Trajectory and Leadership Shift in Nordic Biotech Ecosystem
Private CompaniesActithera Highlights Growth Trajectory and Leadership Shift in Nordic Biotech Ecosystem
2d ago
ACTIT
Actithera Bolsters Leadership as It Sharpens Focus on Next-Generation Oncology
PremiumPrivate Companies
Actithera Bolsters Leadership as It Sharpens Focus on Next-Generation Oncology
6d ago
ACTIT
Actithera Highlights Strategic Focus on Next-Generation Oncology Modalities
PremiumPrivate Companies
Actithera Highlights Strategic Focus on Next-Generation Oncology Modalities
7d ago
ACTIT
Actithera Strengthens Leadership Team Ahead of Clinical Advancement
PremiumPrivate Companies
Actithera Strengthens Leadership Team Ahead of Clinical Advancement
8d ago
ACTIT
Actithera Strengthens Radiopharmaceutical Leadership With Key Imaging Hire
PremiumPrivate Companies
Actithera Strengthens Radiopharmaceutical Leadership With Key Imaging Hire
21d ago
ACTIT
Actithera Strengthens Clinical Leadership With Veteran Radiopharmaceutical Executive
PremiumPrivate CompaniesActithera Strengthens Clinical Leadership With Veteran Radiopharmaceutical Executive
23d ago
ACTIT
Actithera Deepens AI-Driven Radiopharmaceutical Strategy With Global Conference Push
Premium
Private Companies
Actithera Deepens AI-Driven Radiopharmaceutical Strategy With Global Conference Push
3M ago
ACTIT
Actithera Deepens Radiopharmaceutical Footprint With AI, FAP Theranostics and Global Ecosystem Push
Premium
Private Companies
Actithera Deepens Radiopharmaceutical Footprint With AI, FAP Theranostics and Global Ecosystem Push
3M ago
ACTIT
Actithera Highlights Focus on AI-Enabled Drug Discovery and Radioligand Therapies
PremiumPrivate Companies
Actithera Highlights Focus on AI-Enabled Drug Discovery and Radioligand Therapies
3M ago
ACTIT
Actithera Highlights Role in Oslo Radiopharmaceutical Ecosystem Symposium
PremiumPrivate Companies
Actithera Highlights Role in Oslo Radiopharmaceutical Ecosystem Symposium
3M ago
ACTIT
Actithera Deepens Radiopharmaceutical Ecosystem Ties With Oslo Event and Global Conference Push
PremiumPrivate Companies
Actithera Deepens Radiopharmaceutical Ecosystem Ties With Oslo Event and Global Conference Push
3M ago
ACTIT
Actithera Highlights Role in Oslo Radiopharmaceutical Ecosystem Event
PremiumPrivate Companies
Actithera Highlights Role in Oslo Radiopharmaceutical Ecosystem Event
3M ago
ACTIT
Actithera – Weekly Recap
PremiumPrivate CompaniesActithera – Weekly Recap
3M ago
ACTIT
Actithera Steps Up FAP Theranostic Focus and Strategic Outreach Ahead of SNMMI 2026
Premium
Private Companies
Actithera Steps Up FAP Theranostic Focus and Strategic Outreach Ahead of SNMMI 2026
4M ago
ACTIT
Actithera CMO to Join Expert Panel on FAP-Targeted Theranostics at SNMMI 2026
Premium
Private Companies
Actithera CMO to Join Expert Panel on FAP-Targeted Theranostics at SNMMI 2026
4M ago
ACTIT
Actithera Highlights CMO Participation in FAP-Focused Oncology Symposium
PremiumPrivate Companies
Actithera Highlights CMO Participation in FAP-Focused Oncology Symposium
4M ago
ACTIT
Actithera Targets Networking and Oncology Partnerships at 2026 SNMMI Meeting
PremiumPrivate Companies
Actithera Targets Networking and Oncology Partnerships at 2026 SNMMI Meeting
4M ago
ACTIT
Actithera Highlights Covalent Radioligand Strategy and Disciplined Deal-Making in Weekly Update
PremiumPrivate Companies
Actithera Highlights Covalent Radioligand Strategy and Disciplined Deal-Making in Weekly Update
4M ago
ACTIT
Actithera Underscores Covalent Radioligand Strategy and Disciplined Deal-Making in Weekly Update
PremiumPrivate Companies
Actithera Underscores Covalent Radioligand Strategy and Disciplined Deal-Making in Weekly Update
4M ago
ACTIT
Actithera Emphasizes Disciplined Search and Evaluation in Biotech Deal Strategy
PremiumPrivate CompaniesActithera Emphasizes Disciplined Search and Evaluation in Biotech Deal Strategy
4M ago
ACTIT
Actithera Highlights Covalent Radioligand Strategy and Long-Term Oncology Focus in Weekly Update
Premium
Private Companies
Actithera Highlights Covalent Radioligand Strategy and Long-Term Oncology Focus in Weekly Update
4M ago
ACTIT
Actithera Showcases Covalent Radioligand Strategy at PEGS Summit
Premium
Private Companies
Actithera Showcases Covalent Radioligand Strategy at PEGS Summit
4M ago
ACTIT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >